BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17578782)

  • 1. An HIV-positive man with tattoo induration.
    López-Medrano F; Costa JR; Rodriguez-Peralto JL; Aguado JM
    Clin Infect Dis; 2007 Jul; 45(2):220-1, 267-8. PubMed ID: 17578782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Raised tattoos in a human-immunodeficiency-virus-infected patient].
    García-Lázaro M; Villar C; Natera C; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):602-4. PubMed ID: 19419796
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
    Alsina-Gibert M; López-Lerma I; Martinez-Chamorro E; Herrero-Mateu C
    Arch Dermatol; 2006 Jun; 142(6):787-9. PubMed ID: 16785393
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
    Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
    Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].
    Burbach G; May J; Harms G; Bienzle U
    Dtsch Med Wochenschr; 1999 Jan; 124(4):88-93. PubMed ID: 10071606
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis presenting as subcutaneous nodules in a HIV-positive patient.
    Göbels K; Feldt T; Oette M; Richter J; Harms G; Grobusch MP; Sarbia M; Häussinger D
    Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):329-31. PubMed ID: 12736797
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
    Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
    An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
    Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
    Hernández DE; Oliver M; Martínez C; Planas G
    Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768
    [No Abstract]   [Full Text] [Related]  

  • 15. Visceral leishmaniasis in HIV-infected patients.
    del Mar Sanz M; Rubio R; Casillas A; Guijarro C; Costa JR; Martinez R; de Dios Garcia J
    AIDS; 1991 Oct; 5(10):1272-4. PubMed ID: 1786161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visceral leishmaniasis and HIV infection: the diagnostic and therapeutic problems].
    Rocha PS; Rebocho L; Alvoeiro L; Lourenço G; Branco R; Victorino RM; de Moura MC
    Acta Med Port; 1993 Nov; 6(11):543-6. PubMed ID: 8140923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetrical cutaneous leishmaniasis.
    Guarneri C; Guarneri F
    Acta Derm Venereol; 2005; 85(3):281-2. PubMed ID: 16040429
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ; Aminjavaheri M
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Back from the Peace Corps--with skin lesions from South America.
    Sorci JJ; Cordova X; Usatine RP
    J Fam Pract; 2003 Jul; 52(7):531-6. PubMed ID: 12884834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.